Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GLIMEPIRIDE\ROSIGLITAZONE: 717 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
717
Total FAERS Reports
74 (10.3%)
Deaths Reported
487
Hospitalizations
717
As Primary/Secondary Suspect
2
Disabilities

Active Ingredient: GLIMEPIRIDE\ROSIGLITAZONE MALEATE ·

First Report: 19990609 · Latest Report: 20160104

What Are the Most Common GLIMEPIRIDE\ROSIGLITAZONE Side Effects?

#1 Most Reported
Myocardial infarction
259 reports (36.1%)
#2 Most Reported
Cardiac failure congestive
225 reports (31.4%)
#3 Most Reported
Cerebrovascular accident
144 reports (20.1%)

All GLIMEPIRIDE\ROSIGLITAZONE Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Myocardial infarction 259 36.1% 45 183
Cardiac failure congestive 225 31.4% 25 158
Cerebrovascular accident 144 20.1% 13 96
Coronary artery disease 111 15.5% 12 98
Acute myocardial infarction 45 6.3% 6 41
Coronary arterial stent insertion 34 4.7% 1 23
Atrial fibrillation 22 3.1% 4 19
Myocardial ischaemia 18 2.5% 0 16
Chest pain 17 2.4% 1 11
Coronary artery bypass 17 2.4% 1 14
Transient ischaemic attack 17 2.4% 1 14
Cardio-respiratory arrest 15 2.1% 14 8
Cardiac disorder 14 2.0% 5 8
Angina unstable 13 1.8% 1 12
Hypertension 13 1.8% 1 7
Vascular graft 12 1.7% 0 10
Angina pectoris 11 1.5% 0 10
Arteriosclerosis coronary artery 11 1.5% 6 7
Cardiac arrest 11 1.5% 10 6
Acute coronary syndrome 8 1.1% 1 7

Who Reports GLIMEPIRIDE\ROSIGLITAZONE Side Effects? Age & Gender Data

Gender: 43.0% female, 57.0% male. Average age: 59.5 years. Most reports from: COUNTRY NOT SPECIFIED. View detailed demographics →

Is GLIMEPIRIDE\ROSIGLITAZONE Getting Safer? Reports by Year

YearReportsDeathsHosp.
2000 2 0 2
2001 7 0 7
2002 6 0 5
2003 12 0 12
2004 20 0 20
2005 31 4 29
2006 63 7 56
2007 98 11 84
2008 82 10 67
2009 69 12 61
2010 78 12 68
2011 15 1 13
2012 4 1 2
2014 1 0 1
2015 1 0 0
2016 1 0 0

View full timeline →

What Is GLIMEPIRIDE\ROSIGLITAZONE Used For?

IndicationReports
Diabetes mellitus 687
Type 2 diabetes mellitus 20

GLIMEPIRIDE\ROSIGLITAZONE vs Alternatives: Which Is Safer?

GLIMEPIRIDE\ROSIGLITAZONE vs GLIPIZIDE GLIMEPIRIDE\ROSIGLITAZONE vs GLIVEC GLIMEPIRIDE\ROSIGLITAZONE vs GLOFITAMAB GLIMEPIRIDE\ROSIGLITAZONE vs GLOFITAMAB-GXBM GLIMEPIRIDE\ROSIGLITAZONE vs GLUCAGON GLIMEPIRIDE\ROSIGLITAZONE vs GLUCAGON\GLUCAGON\WATER GLIMEPIRIDE\ROSIGLITAZONE vs GLUCARPIDASE GLIMEPIRIDE\ROSIGLITAZONE vs GLUCOPHAGE GLIMEPIRIDE\ROSIGLITAZONE vs GLUCOSAMINE GLIMEPIRIDE\ROSIGLITAZONE vs GLUTAMINE

Official FDA Label for GLIMEPIRIDE\ROSIGLITAZONE

Official prescribing information from the FDA-approved drug label.